DNMT3A mutant leukemia cells primed to "fork it over" under DNA damage.

Mutations in the gene DNMT3A have been identified in various hematopoietic conditions including clonal hematopoiesis, myelodysplastic syndrome, and acute myeloid leukemia. The clinical significance of this early mutation and the resultant enhanced clonal fitness have been a focus for therapeutic intervention.